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β-Ketoacyl-ACP synthases (KASs) belong to an important
family of structurally and functionally related condensing
enzymes that play critical roles in the biosynthesis of a
variety of natural products, including fatty acids, the
polyketide precursors of commercially important pharma-
cological agents, and the mycolic acid precursor for the
cell wall of disease-causing mycobacteria. These enzymes
have been recent targets for the engineering of novel
plant-seed oils [1], and for the development of new drugs
for the treatment of cancer [2] and tuberculosis [3]. In the
type II fatty acid synthesis systems of plants and the
majority of prokaryotes, multiple forms of KAS (I–III)
have been identified that have different substrate speci-
ficities. KASIII catalyzes the elongation of an acetyl-CoA
primer by malonyl-ACP, whereas KASI and KASII, which
have overlapping specificities, utilize only acyl-ACP for
elongation by malonyl-ACP [4]. Active KASI and KASII
are both homodimers that efficiently elongate 6:0-ACP
through 14:0-ACP substrates [5]. We have recently solved
the crystal structures of KASII alone and complexed with
cerulenin [6,7]. Here we have exploited the structural
information to predict which amino acid(s), when replaced
by bulkier residues, would provide a reduction in the size
of the acyl-chain-binding pocket and have demonstrated
experimentally that indeed these substitutions limit acyl-
chain-length acceptance to 6:0-ACP substrate.
The recently solved crystal structure of KASII complexed
with cerulenin, a 12-carbon mycotoxin that irreversibly
inhibits the condensing enzyme by forming a covalent
linkage to the active-site cysteine residue (Cys163), has
provided some insight into the structural basis for the sub-
strate specificity of the enzyme [7]. This structure
revealed that the hydrocarbon chain of cerulenin is located
in a hydrophobic pocket surrounded by residues Ala162,
Gly107, Leu342, Phe202, Leu111, Ile108, Ala193 and
Gly198 from one subunit, and Ile138, Val134 and Phe133
from the second subunit. 
Using molecular modelling with the MSI package [8], we
predicted that replacement of the sidechains at Ala193 or
Ile108 with more bulky or longer hydrophobic residues
might decrease the size of the hydrophobic pocket, thus
hindering access of long chain-length substrates. Using the
Figure 1
Stereoview of the acyl-binding pocket
containing the introduced amino acid
substitutions that shortened the acyl-chain-
binding pocket of the Escherichia coli KASII.
The residues marked with asterisks belong to
the second subunit. The docked ligand,
[CH3(CH2)8CO], a ten-carbon acyl chain
(yellow) conjugated via its carbonyl group
(red) to the Sγ atom of Cys163 by means of a
thioester linkage (blue), has been modelled to
show its position in relation to the
Ile108→Phe mutant (magenta) and the
Ala193→Met mutant (purple).
atomic coordinates for the enzyme determined from the
KASII–cerulenin complex, we modelled into the structure
acyl chains containing 6–14 carbon atoms that were conju-
gated to the Sγ atom of Cys163. By varying the dihedral
angles of the mutant sidechains and the fatty acyl chain an
ensemble of sterically fitted conformers were obtained. On
the basis of these data, we predicted specifically that muta-
tion of Ile108→Phe and Ala193→Met would limit access to
the shorter acyl-chain-length substrates (Figure 1). In
agreement with this prediction the calculated volume of
the hydrophobic acyl-binding pocket decreased from
184 Å3 for the wild-type enzyme to 105 Å3 for Ile108→Phe
and 72 Å3 for Ala193→Met mutant models. 
The validity of these predictions was tested by performing
enzyme assays with affinity-purified recombinant
enzymes using acyl-ACP substrates, 6:0–14:0-ACP. The
resultant data revealed that indeed both of these muta-
tions limited the substrate acceptance to 6:0-ACP
(Figure 2a). Surprisingly, the Ala193→Met mutant
enzyme was 25–30% more active with the 6:0-ACP sub-
strate than was the wild-type enzyme. The activities of
the mutant enzymes towards 8:0-ACP were 38-fold less for
Ile108→Phe and 12-fold less for Ala193→Met, compared
with their corresponding activities with the 6:0-ACP sub-
strate. With each additional two-carbon increase in acyl-
ACP chain length the mutant enzymes showed additional,
though less dramatic, decreases in activity. Further evi-
dence in support of these data was provided by determin-
ing whether or not the 12-carbon long mycotoxin
cerulenin retained its inhibitory activity toward the
mutant enzymes (Figure 2b). Both Ile108→Phe and
Ala193→Met mutants maintained up to 90% of their activ-
ity even in the presence of 50 µM cerulenin, whereas the
wild-type enzyme was totally inactivated at this concentra-
tion. Together, the results of the enzyme assays in the
presence and absence of the inhibitor confirmed that
these two amino acids play key roles in determining the
size of the fatty acid substrate binding pocket and hence
the chain length specificity of the enzyme. 
These results provide the first major insight into the struc-
tural elements that contribute to the substrate specificity
of this important class of enzymes.
Materials and methods
Site-directed mutagenesis, enzyme purification and 
activity assays
Site directed mutations were introduced by Quikchange (Stratagene,
La Jolla, CA). Recombinant enzymes were expressed, purified and
assayed as described [5]. 
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Figure 2
Enzyme activity and cerulenin inhibition studies. (a) Acyl-ACP
substrate specificities of affinity-purified recombinant wild-type and
mutant enzymes. (b) Effect of cerulenin on wild-type and mutant
enzyme activities. Enzymes were incubated with various concentrations
of cerulenin prior to addition of 6:0-ACP substrate.
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